Clinical Pathways: An Evolutionary Approach to Cancer Care
Clinical pathway programs are evolving as a primary means by which payers intend to control drug utilization in cancer treatment.
Is Our Healthcare System Ready to Integrate Cancer Care?
In response to the billions of dollars wasted each year in the United States on fragmented, ineffective, and uncoordinated care, some healthcare reform efforts have focused on integrating the delivery of healthcare.
AACR President Frank McCormick, PhD, Reflects on Past Progress and Looks to the Future
An interesting conversation with this year's AACR president, Frank McCormick, PhD, on the next big area of interest in cancer research, and what the future holds for cancer research progress.
Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care
Dr Habib on Developments in Palliative Care For Patients With Cancer
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations
2 Clarke Drive Cranbury, NJ 08512